126 related articles for article (PubMed ID: 6140748)
1. Fasting plasma somatostatin in alcoholic liver disease.
Kelbaek H; Tronier B; Bahnsen M; Munkgaard S; Pedersen H
Scand J Clin Lab Invest; 1983 Nov; 43(7):597-601. PubMed ID: 6140748
[TBL] [Abstract][Full Text] [Related]
2. [Somatostatin plasma level in patients with liver cirrhosis].
Tulassay Z; Tulassay T; Szabó A; Jaszovszky I; Gohér A
Orv Hetil; 1995 May; 136(22):1163-5. PubMed ID: 7761079
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of determining serum levels of glycocholic acid in alcoholic lesions of the liver].
Bocharova LV; Tsodikov GV; Chernyshova NN; Kataev SS; Burkov SG
Klin Med (Mosk); 1992; 70(7-8):41-4. PubMed ID: 1460824
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis.
Pereira LM; Langley PG; Bird GL; Hayllar KM; Tredger JM; Williams R
Alcohol Alcohol; 1992 Jan; 27(1):55-61. PubMed ID: 1580929
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
Campillo B; Sherman E; Richardet JP; Bories PN
Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
[TBL] [Abstract][Full Text] [Related]
8. Colchicine clearance is impaired in alcoholic cirrhosis.
Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
[TBL] [Abstract][Full Text] [Related]
9. Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis.
Langmann P; Bienert A; Zilly M; Väth T; Richter E; Klinker H
Eur J Med Res; 2000 May; 5(5):217-21. PubMed ID: 10806124
[TBL] [Abstract][Full Text] [Related]
10. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein A in patients with alcoholic liver disease].
Kostić N; Bozanić M; Cvetković R; Lalević S
Srp Arh Celok Lek; 1990; 118(3-4):109-12. PubMed ID: 17977396
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma somatostatin in cirrhosis of the liver.
Munkgaard S; Kelbaek H; Tronier B
N Engl J Med; 1981 Jun; 304(23):1429-30. PubMed ID: 6112708
[No Abstract] [Full Text] [Related]
13. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.
Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO
Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251
[TBL] [Abstract][Full Text] [Related]
14. [Serum interleukin-6 concentrations in patients with alcoholic liver disease].
Swiatkowska-Stodulska R; Bakowska A
Pol Merkur Lekarski; 2004 Sep; 17(99):255-9. PubMed ID: 15628053
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
[TBL] [Abstract][Full Text] [Related]
17. Circadian variations of plasma somatostatin levels in healthy subjects.
Strazzulla G; Guazzelli R; Romano S; Matassi L; Cotrozzi G; Brocchi A
Chronobiologia; 1990; 17(3):219-25. PubMed ID: 1977563
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease.
Henriksen JH; Bentsen KD; Laurent TC
J Hepatol; 1988 Apr; 6(2):158-66. PubMed ID: 3411097
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
20. [Phenotype study of blood T lymphocytes in alcoholic hepatopathies].
Pelletier G; Segond P; Attali P; Briantais MJ; Etienne JP
Gastroenterol Clin Biol; 1984 Dec; 8(12):911-4. PubMed ID: 6394417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
